Edgar Lomax Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.4M | Sell |
152,850
-205,645
| -57% | -$23.7M | 1.31% | 33 |
|
|
2025
Q4 | $37.7M | Sell |
358,495
-201,705
| -36% | -$18.9M | 2.87% | 9 |
|
|
2025
Q3 | $47M | Sell |
560,200
-164,405
| -23% | -$13.5M | 3.68% | 9 |
|
|
2025
Q2 | $57.4M | Sell |
724,605
-12,015
| -2% | -$955K | 3.63% | 8 |
|
|
2025
Q1 | $66.1M | Buy |
736,620
+105,035
| +17% | +$9.81M | 4.13% | 6 |
|
|
2024
Q4 | $62.8M | Buy |
+631,585
| New | +$65.1M | 4.05% | 4 |
|
|
2024
Q1 | – | Sell |
-277,069
| Closed | -$30.2M | – | 70 |
|
|
2023
Q4 | $30.2M | Sell |
277,069
-11,375
| -4% | -$1.18M | 1.97% | 22 |
|
|
2023
Q3 | $29.7M | Sell |
288,444
-5,255
| -2% | -$566K | 2.02% | 21 |
|
|
2023
Q2 | $33.9M | Sell |
293,699
-4,121
| -1% | -$468K | 2.23% | 21 |
|
|
2023
Q1 | $31.7M | Sell |
297,820
-580,555
| -66% | -$62.7M | 2.04% | 21 |
|
|
2022
Q4 | $97.5M | Sell |
878,375
-5,090
| -0.6% | -$520K | 5.91% | 1 |
|
|
2022
Q3 | $76.1M | Sell |
883,465
-6,650
| -0.7% | -$594K | 5.26% | 2 |
|
|
2022
Q2 | $81.2M | Buy |
890,115
+22,305
| +3% | +$1.98M | 5.08% | 2 |
|
|
2022
Q1 | $71.2M | Buy |
867,810
+309,360
| +55% | +$24.4M | 4.18% | 7 |
|
|
2021
Q4 | $42.8M | Sell |
558,450
-5,445
| -1% | -$434K | 2.56% | 15 |
|
|
2021
Q3 | $42.4M | Sell |
563,895
-5,635
| -1% | -$429K | 2.72% | 11 |
|
|
2021
Q2 | $44.3M | Sell |
569,530
-43,005
| -7% | -$3.2M | 2.75% | 10 |
|
|
2021
Q1 | $45.1M | Buy |
+612,535
| New | +$45.2M | 2.81% | 10 |
|
|
2019
Q1 | – | Sell |
-549,244
| Closed | -$40M | – | 74 |
|
|
2018
Q4 | $40M | Sell |
549,244
-8,227
| -1% | -$581K | 3.04% | 12 |
|
|
2018
Q3 | $37.7M | Sell |
557,471
-20,090
| -3% | -$1.28M | 2.53% | 15 |
|
|
2018
Q2 | $33.5M | Buy |
577,561
+4,035
| +0.7% | +$228K | 2.35% | 17 |
|
|
2018
Q1 | $29.8M | Buy |
573,526
+429,208
| +297% | +$23.2M | 2.14% | 17 |
|
|
2017
Q4 | $7.75M | Sell |
144,318
-4,313
| -3% | -$239K | 0.53% | 50 |
|
|
2017
Q3 | $9.08M | Sell |
148,631
-13,065
| -8% | -$792K | 0.64% | 45 |
|
|
2017
Q2 | $9.89M | Sell |
161,696
-4,506
| -3% | -$274K | 0.68% | 44 |
|
|
2017
Q1 | $10.1M | Sell |
166,202
-1,061,560
| -86% | -$64.4M | 0.67% | 43 |
|
|
2016
Q4 | $69M | Sell |
1,227,762
-116,058
| -9% | -$6.79M | 4.42% | 6 |
|
|
2016
Q3 | $80M | Sell |
1,343,820
-702
| -0.1% | -$41.1K | 4.96% | 3 |
|
|
2016
Q2 | $73.9M | Buy |
1,344,522
+67,236
| +5% | +$3.58M | 4.64% | 6 |
|
|
2016
Q1 | $64.5M | Buy |
1,277,286
+171,244
| +15% | +$8.39M | 4.43% | 6 |
|
|
2015
Q4 | $55.7M | Buy |
1,106,042
+535,213
| +94% | +$27M | 4.09% | 9 |
|
|
2015
Q3 | $26.9M | Sell |
570,829
-20,017
| -3% | -$1.06M | 2.04% | 21 |
|
|
2015
Q2 | $32.1M | Sell |
590,846
-7,388
| -1% | -$414K | 2.15% | 20 |
|
|
2015
Q1 | $32.8M | Buy |
598,234
+16,239
| +3% | +$920K | 2.14% | 20 |
|
|
2014
Q4 | $31.5M | Buy |
581,995
+3,741
| +0.6% | +$208K | 1.97% | 18 |
|
|
2014
Q3 | $32.7M | Buy |
578,254
+14,850
| +3% | +$834K | 2.22% | 18 |
|
|
2014
Q2 | $31.1M | Buy |
563,404
+1,965
| +0.3% | +$107K | 2.2% | 18 |
|
|
2014
Q1 | $30.4M | Sell |
561,439
-6,943
| -1% | -$360K | 2.24% | 18 |
|
|
2013
Q4 | $27.1M | Buy |
568,382
+21,484
| +4% | +$982K | 2.05% | 21 |
|
|
2013
Q3 | $24.8M | Sell |
546,898
-50,618
| -8% | -$2.31M | 2.04% | 20 |
|
|
2013
Q2 | $26.5M | Buy |
+597,516
| New | +$26.7M | 2.06% | 21 |
|
Other funds holding MRK
VCM
VPM
Edgar Lomax Company's MRK Position: Q1 2026 in Review
Edgar Lomax Company reduced its Merck (MRK) stake by 57% in Q1 2026, selling an estimated $23.7M and leaving 152,850 shares worth $18.4M. The position accounts for 1.31% of the portfolio, ranked #33.
Edgar Lomax Company first reported a position in MRK in Q2 2013 and has held it in 41 quarters since. The position peaked at $97.5M in Q4 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Edgar Lomax Company held 152,850 shares of Merck worth $18.4M as of Q1 2026.
- Edgar Lomax Company sold 205,645 Merck shares in Q1 2026, an estimated $23.7M.
- Merck made up 1.31% of Edgar Lomax Company's portfolio in Q1 2026, its #33 holding.
- Edgar Lomax Company first reported a position in Merck in Q2 2013 and has held it in 41 quarters since.
- Edgar Lomax Company's Merck position peaked at $97.5M in Q4 2022.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Edgar Lomax Company's 13F filing for Q1 2026, filed 12 May 2026.